Phasix is a new and very expensive product. Final clinical trials outcomes have not been shared yet.
It’s an interesting idea, but there is no proof yet that scar tissue left behind is enough to prevent a recurrence. It may just delay the time at which you gain a recurrence. We will know more in 1-2 years.
TIGR mesh has had some success in Europe. It is not widely available in the US.
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.